Can FDI fix Nigeria’s broken healthcare infrastructure?
Nigeria's healthcare infrastructure is in desperate need of greater investment in order to ensure that not just the wealthy have access to adequate care.
Healthcare
Healthcare
Virti: The investment journey of a start-up
Digital training start-up Virti has gone from an idea to a highly successful reality in the space of three years. Investment Monitor tracks this journey and looks at the role investment has played.
How Coyol Free Zone protected and thrived during Covid-19
Coyol Free Zone in Costa Rica excelled in Investment Monitor's inaugural Economic Zone Sustainable Recovery Strategies Awards, with judges commending its ability to attract investment and reinvestment from clients in the wake of Covid-19.
Coyol Free Zone
SDG focus: Covid-19’s wider health impact
The Covid-19 pandemic has exposed a series of weaknesses in the global healthcare system, making the achievement of SDG3 – good health and well-being – seem like a distant dream. Can FDI get it back on track?
The state of play: FDI in Cuba
FDI information on Cuba is sketchy, but it seems that the country has been hit by a reduction in remittances as a result of the Covid-19 crisis.
White Papers
Partner content
The big interview: Cisco’s David Meads
He has already overseen the UK medical sector’s biggest peacetime IT infrastructure project – fitting out the 4,000-bed Nightingale hospital in London’s ExCeL centre in just nine days. Now, Cisco UK and Ireland CEO David Meads wants to bring 'digital equality' to the UK post-Covid-19.
Sustainable investing brings foreign investors to Brazil
Brazil’s sustainable investing landscape has been increasingly appearing on the radars of foreign investors in recent years.
Pharma FDI in the times of Covid-19: A challenging pill to swallow
With supply chains disrupted and the world veering all its attention towards halting Covid-19, FDI flows into the pharmaceutical sector will strongly depend on countries’ ability to respond to the epidemic, and their overall stability.
Cross-border dealmaking dwindles as Covid-19 hits
The cross-border dealmaking environment was looking in healthy shape until the global Covid-19 outbreak. Now 2020 M&A activity looks set to plumb new depths.
